Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
6.42
-0.13 (-1.98%)
Apr 1, 2025, 3:49 PM EDT - Market open
Tenax Therapeutics Employees
As of December 31, 2023, Tenax Therapeutics had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees decreased by 2 or -25.00% compared to the previous year.
Employees
6
Change (1Y)
-2
Growth (1Y)
-25.00%
Revenue / Employee
n/a
Profits / Employee
-$2,933,667
Market Cap
230.18M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TENX News
- 1 day ago - Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 days ago - Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 27 days ago - Tenax Therapeutics Announces $25 Million Private Placement - GlobeNewsWire
- 27 days ago - Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF - GlobeNewsWire
- 4 weeks ago - Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference - GlobeNewsWire
- 4 months ago - Tenax Therapeutics, Inc. (TENX) Guggenheim Healthcare Innovation Conference (Transcript) - Seeking Alpha
- 4 months ago - Tenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewsWire